Understanding Your Child's Diagnosis of Hereditary Folate Malabsorption

The day your child received a diagnosis of Hereditary Folate Malabsorption (HFM) likely brought a mix of relief that you finally have an answer and overwhelming uncertainty about what it means for your child’s future. It is important to know that you are navigating one of the rarest medical conditions in the world. HFM is very rare and the exact prevalence is unknown; most of our knowledge comes from case reports documented in the medical literature ^[1][2].

Because HFM is so rare, your local pediatrician or even your local hospital staff may never have seen a case before. This rarity often leads to a long, frightening diagnostic journey for parents. Finding this answer is a critical first step toward a specific, actionable treatment path.

Understanding the Impaired Transporter (PCFT)

To understand HFM, it helps to look at how the body normally handles folate (Vitamin B9). Folate is essential for making DNA, producing red blood cells, and ensuring the brain and nervous system develop correctly ^[2].

Your child’s body has pathogenic variants in a specific gene called SLC46A1. This gene is the blueprint for a protein called the Proton-Coupled Folate Transporter (PCFT) ^[2][3].

• The Normal Role of PCFT: Think of PCFT as a specialized doorway. In a healthy body, these transporters live in the lining of the small intestine to pull folate from food into the bloodstream. They also live in a part of the brain called the choroid plexus, where they transport folate from the blood into the cerebrospinal fluid (CSF) to support the central nervous system ^[2][4].
• What Happens in HFM: In children with HFM, these transporters are impaired or missing due to the genetic changes. This creates a two-part problem: the body cannot adequately absorb folate from the diet (systemic deficiency), and it cannot effectively move what little folate it has into the cerebrospinal fluid (cerebral deficiency) ^[2][5].

Why Symptoms Often Wait to Appear

One of the most confusing aspects of HFM is that babies often appear perfectly healthy at birth. This is because, during pregnancy, the mother’s body provides the baby with folate. A newborn often starts life with enough folate stores to support initial development ^[6].

However, as the baby grows rapidly in the first few weeks of life, they use those stored supplies quickly. Because their PCFT transporters aren’t working, they cannot adequately replenish their stores through breast milk or formula. Once those initial stores run low—often between 2 and 4 months of age—symptoms such as anemia, immune system issues, or neurological signs begin to emerge ^[6][7].

Affecting the Body and the Central Nervous System

HFM is unique because it causes deficiency in two different systems at the same time:

1. Systemic Deficiency: Without adequate folate in the blood, the body struggles to make healthy red blood cells, leading to a type of anemia where cells are abnormally large (megaloblastic anemia). It can also weaken the immune system, making the child more prone to infections ^[2][1].
2. Cerebral Deficiency: This is the more hidden part of the condition. Even if blood levels of folate are boosted, the central nervous system may still be deficient because the transporters at the blood-brain barrier are impaired ^[8][4]. Without adequate folate, the brain cannot develop or function correctly, which can lead to seizures or developmental delays if left untreated ^[1][6].

A Path Forward: Folinic Acid

While the diagnosis is serious, there is a specific, prescription treatment that offers significant hope. Standard, over-the-counter folic acid (the kind found in most vitamins) is usually not effective because it relies heavily on the impaired PCFT transporters to enter the system and the brain ^[8].

Instead, doctors prescribe a different form called folinic acid (also known as leucovorin, or in its active form, levofolinic acid). When given in specific, prescribed doses, folinic acid can use different cellular pathways to bypass the impaired PCFT transporters and enter the cells and the central nervous system ^[8][9]. Research has shown that with the right individualized dose and formulation—sometimes requiring injections to ensure enough reaches the brain—many of the systemic and neurological symptoms can be improved ^[9][6]. Your medical team will focus on monitoring both the blood and the cerebrospinal fluid to ensure your child is getting the exact amount they need to thrive.